May 19, 2005
1
Tipranavir
NDA 21-814:
Exposure Response Analysis
Exposure Response Analysis
Jenny J Zheng,
Ph.D.
Pharmacometrics
Reviewer
Office
of Clinical Pharmacology and Biopharmaceutics
CDER,
FDA
FDA Antiviral Drugs Advisory
Committee Meeting